BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
Macquariee Maintains 'Outperform' on Fortis Healthcare
Macquaire has maintained its 'outperform' rating on Fortis Healthcare with a target price of Rs 225/share. Macquarie says Fortis' domestic hospital business profitability is at an inflection point. It sees strong EBITDA growth in next 2-3 years and says that Fortis is at an early phase in its growth cycle.